We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.21B
AUM Growth
+$110M
Cap. Flow
-$79.3M
Cap. Flow %
-3.59%
Top 10 Hldgs %
22.7%
Holding
3,121
New
66
Increased
341
Reduced
717
Closed
30

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$3.73M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.01M
3
COP icon
ConocoPhillips
COP
+$2.6M
4
NOW icon
ServiceNow
NOW
+$1.95M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.95M

Top Sells

Rank Stock Value
1
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.14M
2
MSFT icon
Microsoft
MSFT
+$4.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$3.96M
4
TER icon
Teradyne
TER
+$3.85M
5
ETSY icon
Etsy
ETSY
+$3.81M

Sector Composition

Rank Sector Weight
1 Technology 17.97%
2 Consumer Discretionary 10.47%
3 Healthcare 9.98%
4 Financials 9.67%
5 Industrials 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECVT icon
2101
Ecovyst
ECVT
$1.09B
$32K ﹤0.01%
3,089
– –
FORR icon
2102
Forrester Research
FORR
$220M
$32K ﹤0.01%
966
– –
GBIO
2103
DELISTED
Generation Bio
GBIO
$32K ﹤0.01%
+105
New +$25.1K
INSW icon
2104
International Seaways
INSW
$4.71B
$32K ﹤0.01%
2,158
– –
MLR icon
2105
Miller Industries
MLR
$643M
$32K ﹤0.01%
1,050
– –
PRTA icon
2106
Prothena Corp
PRTA
$466M
$32K ﹤0.01%
3,249
– –
STRL icon
2107
Sterling Infrastructure
STRL
$16.8B
$32K ﹤0.01%
2,268
– –
TG icon
2108
Tredegar Corp
TG
$281M
$32K ﹤0.01%
2,145
– –
URGN icon
2109
UroGen Pharma
URGN
$2.34B
$32K ﹤0.01%
1,653
– –
VKTX icon
2110
Viking Therapeutics
VKTX
$3.84B
$32K ﹤0.01%
5,553
– –
QTTB icon
2111
Q32 Bio
QTTB
$458M
$32K ﹤0.01%
167
– –
SYRS
2112
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$32K ﹤0.01%
367
– –
CNSL
2113
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$32K ﹤0.01%
5,584
– –
VRAY
2114
DELISTED
ViewRay, Inc.
VRAY
$32K ﹤0.01%
9,151
– –
POLY
2115
DELISTED
Plantronics, Inc.
POLY
$32K ﹤0.01%
2,716
– –
JCAP
2116
DELISTED
Jernigan Capital, Inc.
JCAP
$32K ﹤0.01%
1,875
– –
DCOM
2117
DELISTED
Dime Community Bancshares
DCOM
$32K ﹤0.01%
2,786
– –
ALXO icon
2118
ALX Oncology
ALXO
$278M
$31K ﹤0.01%
+816
New +$32.1K
ANAB icon
2119
AnaptysBio
ANAB
$1.66B
$31K ﹤0.01%
2,097
– –
AXGN icon
2120
Axogen
AXGN
$2.67B
$31K ﹤0.01%
2,668
– –
CENX icon
2121
Century Aluminum
CENX
$4.59B
$31K ﹤0.01%
4,377
– –
CODX
2122
Co-Diagnostics
CODX
$5.49M
$31K ﹤0.01%
76
– –
FMBH icon
2123
First Mid Bancshares
FMBH
$1.38B
$31K ﹤0.01%
1,248
– –
GRBK icon
2124
Green Brick Partners
GRBK
$3.02B
$31K ﹤0.01%
1,909
– –
HBNC icon
2125
Horizon Bancorp
HBNC
$1.05B
$31K ﹤0.01%
3,088
– –
83 84
85
86 87

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return

Ameritas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Ameritas Investment Partners held 3,121 positions worth $2.21B, up 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ameritas Investment Partners withdrew a net $79.3M in Q3 2020, closing 30 positions and reducing 717 holdings. Its most notable exit was Caesars Entertainment Corporation, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Ameritas Investment Partners opened a new position in Jazz Pharmaceuticals worth $2.24M.

  • Ameritas Investment Partners's largest Q3 2020 buy was Jazz Pharmaceuticals: 15,701 shares worth $2.24M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q3 2020, an estimated $3.73M increase.
  • Ameritas Investment Partners's biggest Q3 2020 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $6.14M.
  • Ameritas Investment Partners fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $1.97M.
  • Ameritas Investment Partners's ten largest holdings make up 23% of its $2.21B portfolio in Q3 2020.
  • Ameritas Investment Partners opened 66 new positions and closed 30 in Q3 2020.
  • Ameritas Investment Partners's portfolio value rose 5.2% quarter-over-quarter to $2.21B.

Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.